All In Biotech

Drug Trial Radar · NCT05660642

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

An Open-Label, Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Last checked: Nov 19, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Feb 10, 2023

Primary completion

Nov 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Beckley Psytech LimitedIndustry
Sponsor type
Industry
First posted
Dec 21, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open-label, multi-centre, Phase 2a study to evaluate the safety, tolerability, and pharmacodynamics of one and two doses of intranasal BPL-003 combined with psychological support, in patients with treatment resistant depression when administered as monotherapy or as adjunctive therapy with defined SSRIs (citalopram, escitalopram, sertraline or fluoxetine).

Conditions

  • Treatment Resistant Depression

Interventions

  • BPL-003Drug

    Experimental BPL-003 arms: will investigate one of two doses of BPL-003 (Part 1) and two doses of BPL-003 (Part 2)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1. To assess the safety and tolerability of single or multiple intranasal doses of BPL-003 in patients with treatment resistant depressionTime frame: Baseline to 12 weeks post dose

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • MAC Clinical Research

    Liverpool, United Kingdom · Recruiting

  • Hammersmith Medicines Research

    London, United Kingdom · Recruiting

  • King's College London, Clinical Trials Facility

    London, United Kingdom · Completed

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.